Return to search results
Lomustine
Gleostine (lomustine) is an oral prescription medication used as a chemotherapy drug to treat certain cancers, such as brain tumors. It works by interfering with cancer cell growth through alkylating activity. Available as capsules in strengths of 10mg, 40mg, and 100mg, it's manufactured by Azurity Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Gleostine (lomustine) is an oral prescription medication used as a chemotherapy drug to treat certain cancers, such as brain tumors. It works by interfering with cancer cell growth through alkylating activity. Available as capsules in strengths of 10mg, 40mg, and 100mg, it's manufactured by Azurity Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Lomustine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Lomustine — ANDA 219265 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219265"
}
]
|
| identifier | ANDA219265 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"health-care",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Lomustine |
